3M to Divest Substantially All of Its Drug Delivery Business to Altaris Capital Partners
ST. PAUL, Minn.–(BUSINESS WIRE)–3M today announced that it has entered into an agreement to sell substantially all of its drug…
Pharmaceuticals, Biotechnology and Life Sciences
ST. PAUL, Minn.–(BUSINESS WIRE)–3M today announced that it has entered into an agreement to sell substantially all of its drug…
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a biopharmaceutical company focused on discovering and developing highly-differentiated therapies for oncology, today announced…
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a biopharmaceutical company focused on discovering and developing highly-differentiated therapies for oncology, today announced…
DUBLIN–(BUSINESS WIRE)–The “Middle East And Africa 3D Cell Culture Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering. The Middle…
Explains Crucial Importance of Strategic Transaction and Partnership with CGP and Sirtex Immediate $30 Million Cash Infusion at a Premium…
Explains Crucial Importance of Strategic Transaction and Partnership with CGP and Sirtex Immediate $30 Million Cash Infusion at a Premium…
New Five-Year Agreement Maintains Exclusive Use of INTERCEPT Platelets and Expands Use of INTERCEPT Plasma CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq:CERS)…
New Five-Year Agreement Maintains Exclusive Use of INTERCEPT Platelets and Expands Use of INTERCEPT Plasma CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq:CERS)…
Successful completion of human factors program ahead of FUROSCIX NDA resubmission BURLINGTON, Mass.–(BUSINESS WIRE)–$SCPH #FUROSCIX–scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical…
Indee Labs announces issuance of patents in the United States, Canada, Japan and Australia for intracellular delivery with a system…